Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients
- PMID: 3568976
- DOI: 10.1002/dc.2840030103
Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients
Abstract
A retrospective analysis of 5,255 pleural effusion specimens from 3,811 patients was undertaken to determine the accuracy of cytopathologic correlation with pleural biopsy, the detection rate of malignancy by cytology, and the frequency distribution of malignant effusions according to age group. The cytopathologic correlation was 96.5% accurate, with 0.1% false-positive results and 0.18% false-negative results by cytology. The sensitivity of cytologic detections was 6.7% higher than that of pleural biopsy. Frequency analysis showed that the incidence of carcinoma of the lung, the most common cause of malignant effusion, is not sex based. Adenocarcinoma of the lung was the most frequent type of malignancy found in pleural effusions. It represented 79% of lung carcinomas that metastasized to pleura, accounting for 40% of all malignant pleural effusions. In young adults, lymphoreticular malignancies were the most common cause of malignant effusions.
Similar articles
-
The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.Monaldi Arch Chest Dis. 2018 Sep 11;88(3):944. doi: 10.4081/monaldi.2018.944. Monaldi Arch Chest Dis. 2018. PMID: 30203633
-
Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.Cancer Cytopathol. 2017 Feb;125(2):128-137. doi: 10.1002/cncy.21790. Epub 2016 Oct 24. Cancer Cytopathol. 2017. PMID: 28207201
-
The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.Cancer Cytopathol. 2015 Apr;123(4):258-66. doi: 10.1002/cncy.21518. Epub 2015 Jan 14. Cancer Cytopathol. 2015. PMID: 25641902
-
Malignancies metastatic to the pleura.Invest Radiol. 1990 May;25(5):601-19. doi: 10.1097/00004424-199005000-00025. Invest Radiol. 1990. PMID: 2188932 Review.
-
Advances in the diagnosis of pleural disease in lung cancer.Ther Adv Respir Dis. 2011 Dec;5(6):409-18. doi: 10.1177/1753465811408637. Epub 2011 Jun 22. Ther Adv Respir Dis. 2011. PMID: 21697244 Review.
Cited by
-
Diagnosis and management of malignant pleural effusions: state of the art in 2017.J Thorac Dis. 2017 Sep;9(Suppl 10):S1111-S1122. doi: 10.21037/jtd.2017.07.79. J Thorac Dis. 2017. PMID: 29214068 Free PMC article. Review.
-
Effectiveness and Safety of Real-Time Transthoracic Ultrasound-Guided Thoracentesis.Diagnostics (Basel). 2022 Mar 16;12(3):725. doi: 10.3390/diagnostics12030725. Diagnostics (Basel). 2022. PMID: 35328278 Free PMC article.
-
Contemporary best practice in the management of malignant pleural effusion.Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618785098. doi: 10.1177/1753466618785098. Ther Adv Respir Dis. 2018. PMID: 29952251 Free PMC article. Review.
-
BTS guidelines for the management of malignant pleural effusions.Thorax. 2003 May;58 Suppl 2(Suppl 2):ii29-38. doi: 10.1136/thorax.58.suppl_2.ii29. Thorax. 2003. PMID: 12728148 Free PMC article. No abstract available.
-
Insights from the European Respiratory Society 2018 Annual International Congress in the fields of thoracic surgery and lung transplantation.J Thorac Dis. 2018 Sep;10(Suppl 25):S3005-S3009. doi: 10.21037/jtd.2018.09.08. J Thorac Dis. 2018. PMID: 30310690 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources